Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Common Shares [Member]	Treasury Shares [Member]	Additional Paid-in Capital [Member]	Retained Earnings (Deficit) [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
Beginning balance at Dec. 31, 2020	$ 1,664,234	$ 2,277	$ (63)	$ 2,235,679	$ (573,576)	$ (83)
Beginning balance (in shares) at Dec. 31, 2020		73,914,844	195,316
Issuance of common shares, net of issuance costs	222,175	$ 45		222,130
Issuance of common shares, net of issuance costs (in shares)		1,353,121
Vesting of restricted shares	3	$ 3
Vesting of restricted shares (in shares)		109,355
Exercise of vested options, net of issuance costs, value	9,784	$ 15		9,769
Exercise of vested options, net of issuance costs (in shares)		342,051
Purchase of common stock under ESPP	751			751
Purchase of common stock under ESPP (in shares)		11,257
Stock-based compensation expense	22,092			22,092
Other comprehensive loss	(378)					(378)
Net (loss) income	(113,163)				(113,163)
Ending balance at Mar. 31, 2021	1,805,498	$ 2,340	$ (63)	2,490,421	(686,739)	(461)
Ending balance (in shares) at Mar. 31, 2021		75,730,628	195,316
Beginning balance at Dec. 31, 2020	1,664,234	$ 2,277	$ (63)	2,235,679	(573,576)	(83)
Beginning balance (in shares) at Dec. 31, 2020		73,914,844	195,316
Net (loss) income	646,062
Ending balance at Jun. 30, 2021	2,603,795	$ 2,352	$ (63)	2,529,649	72,486	(629)
Ending balance (in shares) at Jun. 30, 2021		76,078,453	195,316
Beginning balance at Mar. 31, 2021	1,805,498	$ 2,340	$ (63)	2,490,421	(686,739)	(461)
Beginning balance (in shares) at Mar. 31, 2021		75,730,628	195,316
Vesting of restricted shares (in shares)		3,667
Exercise of vested options, net of issuance costs, value	10,909	$ 12		10,897
Exercise of vested options, net of issuance costs (in shares)		344,158
Stock-based compensation expense	28,331			28,331
Other comprehensive loss	(168)					(168)
Net (loss) income	759,225				759,225
Ending balance at Jun. 30, 2021	2,603,795	$ 2,352	$ (63)	2,529,649	72,486	(629)
Ending balance (in shares) at Jun. 30, 2021		76,078,453	195,316
Beginning balance at Dec. 31, 2021	2,399,460	$ 2,391	$ (63)	2,598,114	(195,915)	(5,067)
Beginning balance (in shares) at Dec. 31, 2021		76,990,066	180,316
Vesting of restricted shares	4	$ 4
Vesting of restricted shares (in shares)		123,564
Exercise of vested options, net of issuance costs, value	10,010	$ 12		9,998
Exercise of vested options, net of issuance costs (in shares)		261,280
Purchase of common stock under ESPP	740			740
Purchase of common stock under ESPP (in shares)		11,495
Stock-based compensation expense	25,745			25,745
Other comprehensive loss	(11,826)					(11,826)
Net (loss) income	(179,217)				(179,217)
Ending balance at Mar. 31, 2022	2,244,916	$ 2,407	$ (63)	2,634,597	(375,132)	(16,893)
Ending balance (in shares) at Mar. 31, 2022		77,386,405	180,316
Beginning balance at Dec. 31, 2021	$ 2,399,460	$ 2,391	$ (63)	2,598,114	(195,915)	(5,067)
Beginning balance (in shares) at Dec. 31, 2021		76,990,066	180,316
Exercise of vested options, net of issuance costs (in shares)	652,333
Net (loss) income	$ (365,051)
Ending balance at Jun. 30, 2022	2,090,831	$ 2,420	$ (63)	2,669,782	(560,966)	(20,342)
Ending balance (in shares) at Jun. 30, 2022		77,792,163	180,316
Beginning balance at Mar. 31, 2022	2,244,916	$ 2,407	$ (63)	2,634,597	(375,132)	(16,893)
Beginning balance (in shares) at Mar. 31, 2022		77,386,405	180,316
Vesting of restricted shares (in shares)		14,705
Exercise of vested options, net of issuance costs, value	10,346	$ 13		10,333
Exercise of vested options, net of issuance costs (in shares)		391,053
Stock-based compensation expense	24,852			24,852
Other comprehensive loss	(3,449)					(3,449)
Net (loss) income	(185,834)				(185,834)
Ending balance at Jun. 30, 2022	$ 2,090,831	$ 2,420	$ (63)	$ 2,669,782	$ (560,966)	$ (20,342)
Ending balance (in shares) at Jun. 30, 2022		77,792,163	180,316